ArticleJournal of health economics and outcomes research2021

Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States.

Katherine Dick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.